- Published at
- by investingnews.com
positive
positive
Canntab Granted 2nd Patent For Immediate Release Cannabidiol Formulation Tablets
Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the “Company” or “Canntab”) is thrilled to announce the Canadian Intellectual Property Office (“CIPO”) has allowed Canadian Patent No. CA 3050150 to Canntab.